The Prevalence of Sleep Apnea in Iran: a Systematic Review and Meta-Analysis

Sarokhani, M and Goli, M and Salarvand, S and Ghanei Gheshlagh, R (2019) The Prevalence of Sleep Apnea in Iran: a Systematic Review and Meta-Analysis. Tanaffos., 18 (1). pp. 1-10.

Full text not available from this repository.
Official URL: https://www.ncbi.nlm.nih.gov/pubmed/31423134

Abstract

BACKGROUND: Sleep apnea is a common sleep disorder which is associated with cardiovascular diseases, diabetes and stroke. Different studies conducted in Iran have reported different prevalence for sleep apnea. The aim of the present study was to determine the prevalence of sleep apnea in Iran. MATERIALS AND METHODS: In this study, 42 studies that have been published in Farsi and English languages were selected with no time limit up to the March of 2018. Article search was conducted using "prevalence", "frequency", "sleep apnea" and "obstructive sleep apnea" keywords in Scientific Information Database (SID), MagIran, Google Scholar, Science Direct, PubMed and Scopus databases. Data were analyzed using meta-analysis and random effect model methods. Heterogeneity between the studies was evaluated using I2 test. Data were analyzed using Stata software version 11.2. RESULTS: The total prevalence of metabolic syndrome was 44% (95% CI: 35% to 53%). The highest prevalence of sleep apnea distinguished by the disease belonged to patients with sleep disorders (74%, 95% CI: 66%-82%), diabetes mellitus (61%; 95% CI: 46%-76%) and cardiovascular disease (55%; 95% CI: 47%-63%). CONCLUSION: Given high prevalence of sleep apnea in Iran, identifying people at risk and providing instructional materials for controlling and treating sleep apnea is necessary.

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine, Health and Life Sciences > School of Medicine
Depositing User: lorestan university
Date Deposited: 08 Sep 2019 04:06
Last Modified: 08 Sep 2019 04:06
URI: http://eprints.lums.ac.ir/id/eprint/1804

Actions (login required)

View Item View Item